Takashi Muranaka
Overview
Explore the profile of Takashi Muranaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kyoda Y, Hashimoto K, Takahashi A, Maehana T, Tachikawa K, Muranaka T, et al.
Curr Urol
. 2024 Aug;
18(2):122-127.
PMID: 39176291
Background: We clarified the predictive factors for changes in the status of medications for lower urinary tract symptoms (LUTS) 2 years after local radiotherapy for nonmetastatic prostate cancer. Materials And...
2.
Muranaka T, Hashimoto K, Shindo T, Shibamori K, Kyoda Y, Kobayashi K, et al.
Curr Urol
. 2022 Oct;
16(3):136-141.
PMID: 36204354
Background: Small cell carcinoma of the urinary bladder (SCUB) is rare. The optimal treatment for SCUB remains unclear. To address the problem of appropriate treatment for each case, we assessed...
3.
4.
Tachikawa K, Nishiyama N, Muranaka T, Takada K, Murase K, Kouno T, et al.
Int Cancer Conf J
. 2019 Jun;
7(1):6-10.
PMID: 31149504
We report the case of a patient who achieved complete remission (CR) of cisplatin-refractory metastatic pure seminoma after treatment with high-dose carboplatin and etoposide (CE) with peripheral blood stem cell...
5.
Hashimoto K, Tabata H, Shindo T, Tanaka T, Hashimoto J, Inoue R, et al.
Urol Oncol
. 2019 May;
37(7):485-491.
PMID: 31103335
Objective: Our aim was to evaluate the usefulness of serum testosterone to guide treatment decision for castration-resistant prostate cancer (CRPC). Methods: We conducted a retrospective analysis of 115 patients with...
6.
Kitamura H, Takahashi A, Takei F, Hotta H, Miyao N, Shindo T, et al.
Anticancer Res
. 2016 Nov;
36(10):5531-5536.
PMID: 27798926
Aim: To determine prognostic factors for overall survival (OS) in renal cell carcinoma (RCC) patients with bone metastasis in the targeted-therapy era. Patients And Methods: We conducted a retrospective multi-institutional...
7.
Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, et al.
J Infect Chemother
. 2015 Jul;
21(9):623-33.
PMID: 26166322
To investigate antimicrobial susceptibility patterns of various bacterial pathogens isolated from complicated urinary tract infection (UTI) cases, the Japanese Society of Chemotherapy, the Japanese Association of Infectious Disease, and the...
8.
Takahashi S, Ichihara K, Hashimoto K, Hiyama Y, Muranaka T, Hashimoto J, et al.
J Infect Chemother
. 2015 Mar;
21(6):464-7.
PMID: 25817353
To evaluate the current methods of surgical antimicrobial prophylaxis from the viewpoint of pharmacokinetics for patients undergo urologic surgery, this study was designed to measure the serum concentrations of two...
9.
Muranaka T, Takahashi S, Hirose T, Hattori A
J Infect Chemother
. 2014 Aug;
20(11):726-8.
PMID: 25129857
Urethral polyp is one of differential diagnoses for the male patients complain of gross-hematuria and/or hematospermia. However, there have been limited numbers of case reports including infectious etiology. Here we...
10.
Kitamura H, Takei F, Nishida S, Muranaka T, Masumori N, Tsukamoto T
Int J Clin Oncol
. 2011 May;
17(1):63-8.
PMID: 21607828
Background: The aim of this study was to evaluate the distribution of lymph node metastasis in extended lymphadenectomy for patients with bladder cancer. Methods: We analyzed 31 patients who underwent...